NICE-recommended weight management strategies include: Dietary intervention aiming for a 600 kcal/day deficit through reduced portion sizes, limiting energy-dense foods, and increasing fruit and vegetable consumption Physical activity building up to 150300 minutes of moderate-intensity aerobic activity weekly, plus muscle-strengthening activities on at least two days weekly, in line with UK Chief Medical Officers' guidelines [10] Behavioural approaches including self-monitoring, goal-setting, and addressing emotional eating patterns Commercial weight management programmes such as those meeting NICE quality standards (QS127) Very-low-calorie diets in specific circumstances, under clinical supervision and for limited periods For patients with a BMI 30 kg/m (or 27.5 kg/m in those of South Asian, Chinese, or other Asian family origin) who have not achieved adequate weight loss through lifestyle measures alone, pharmacological interventions may be considered
During the early stages of its development, BPC 157 primarily garnered attention for its gastroprotective and ulcer-healing properties
A clinically trusted and long-acting B12 solution, Neo-Cytamen contains Hydroxocobalamin a preferred form of Vitamin B12 widely used in medical treatments for its effectiveness and sustained action in the body
It also shifts the body toward burning fat as fuel more readily
Summary: For most people requiring oral supplementation, cyanocobalamin is the most commonly used and effective form of B12, whilst hydroxocobalamin injections are the preferred treatment for confirmed deficiency in UK clinical practice
Packaged in a controlled laboratory environment and prepared for research-use applications
